Categories: News

DataPath examines the effects of COVID-19 on COBRA and upcoming ERISA plan deadlines

LITTLE ROCK, Ark., Feb. 16, 2021 /PRNewswire/ — DataPath, Inc., a leading developer of technology solutions for employee benefits administration, has published a whitepaper titled, “COVID-19 and COBRA Continuation Insurance: Where Do We Stand?” The paper takes a deeper look at the effect of the COVID-19 healthcare crisis on the economy – specifically, its impact on the COBRA insurance market – and how an upcoming deadline could wreak havoc for administrators.

In March 2020, the Federal response to the COVID healthcare crisis included a one year “Outbreak Period,” defined by a joint final notice issued by the Internal Revenue Service and Department of Labor as beginning March 1, 2020 and ending February 28, 2021. With the end looming, third party administrators, employers, and insurance carriers could face some serious issues regarding notices to beneficiaries, COBRA elections, and premium payments, all of which were temporarily suspended for the duration of the Outbreak Period. Without additional Federal guidance, administrators and employers could be facing a massive influx of work, deadlines and not the least, confusion.

“COBRA insurance fills a very specific need for people who lose their group healthcare coverage and are in potential crisis situations,” says John Robbins, Jr, President and CEO of DataPath. “The current situation emphasizes the need for a flexible COBRA software solution that allows administrators to address these needs when so many variables are in play, both now and in the future.”

You can download the whitepaper here.

DataPath will be hosting a webinar on Thursday, February 25, at 10:30 AM (CT) to discuss the whitepaper.

About DataPath: DataPath, Inc. was founded in 1984 and is headquartered in Little Rock, Arkansas. DataPath launched its cloud-based Summit platform in 2017, specifically to handle COBRA and  consumer directed healthcare account administration in a single solution. Learn more at dpath.com.

Contact: Erin Carlile, erin@marketingworks360.com, 614-540-5520

 

View original content:http://www.prnewswire.com/news-releases/datapath-examines-the-effects-of-covid-19-on-cobra-and-upcoming-erisa-plan-deadlines-301228341.html

SOURCE DataPath, Inc.

Staff

Recent Posts

For Pride Month, Mental Health Professionals Offer Parenting Help

Parenting is a hard job under the best of circumstances. It can be especially confusing…

2 hours ago

Curiteva Announces the Beginning of the Commercial Launch of the Inspire(R) Posterior Interbody Solutions

HUNTSVILLE, AL / ACCESSWIRE / June 19, 2024 / Curiteva, Inc., a leading technology and…

2 hours ago

Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically

TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. ("Theralase®" or the…

2 hours ago

Sharecare announces inducement grants under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that…

2 hours ago

Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association

Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people…

2 hours ago

Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry

LOS ANGELES, June 19, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the…

2 hours ago